Published in Cancer Res on July 15, 1991
Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency. Br J Cancer (1994) 1.12
Red oil A5 inhibits proliferation and induces apoptosis in pancreatic cancer cells. World J Gastroenterol (2004) 1.11
Metabolism addiction in pancreatic cancer. Cell Death Dis (2014) 1.02
The Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer. PPAR Res (2009) 0.82
ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma. Medicine (Baltimore) (2016) 0.75
Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer. Hum Gene Ther (1999) 1.77
Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer. Ann Intern Med (1995) 1.75
Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res (1996) 1.59
Calcium and pancreatic secretion. I. Subcellular distribution of calcium and magnesium in the exocrine pancreas of the guinea pig. J Cell Biol (1975) 1.35
Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Proc Natl Acad Sci U S A (1995) 1.35
Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. Proc Natl Acad Sci U S A (2000) 1.19
Altered subcellular distribution of protein kinase C (a phorbol ester receptor). Possible role in tumor promotion and the regulation of cell growth: relationship to changes in adenylate cyclase activity. Adv Cyclic Nucleotide Protein Phosphorylation Res (1985) 1.17
Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors. J Biol Chem (1999) 1.13
sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells. Cancer Res (1997) 1.12
sst2 somatostatin receptor mediates cell cycle arrest and induction of p27(Kip1). Evidence for the role of SHP-1. J Biol Chem (1999) 1.08
Antiproliferative effect of somatostatin and analogs. Chemotherapy (2001) 1.06
A comparison of alcoholic pancreatitis in rat and man. Gut (1971) 1.06
The tyrosine phosphatase SHP-1 associates with the sst2 somatostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling. J Biol Chem (1997) 1.05
Intraduodenal free fatty acids rather than triglycerides are responsible for the release of CCK in humans. Pancreas (1997) 1.02
Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state. J Biol Chem (1998) 1.00
Gastrin stimulates tyrosine phosphorylation of insulin receptor substrate 1 and its association with Grb2 and the phosphatidylinositol 3-kinase. J Biol Chem (1996) 0.96
Glucagon-like peptide-1 binding to rat hepatic membranes. J Endocrinol (1995) 0.96
Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin. Protein Sci (1999) 0.94
Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle. Diabetologia (1994) 0.94
Use of caerulein with submaximal doses of secretin as a test of pancreatic function in man. Gut (1976) 0.93
Quantitation of changes in the expression of multiple genes by simultaneous polymerase chain reaction. Anal Biochem (1993) 0.93
Glucagon-like peptide 1: a potent glycogenic hormone. FEBS Lett (1994) 0.93
Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin. J Biol Chem (1999) 0.92
Effects of somatostatin-14 and somatostatin-28 on bombesin-stimulated release of gastrin, insulin, and glucagon in the dog. Endocrinology (1981) 0.92
Mutation of Asn-391 within the conserved NPXXY motif of the cholecystokinin B receptor abolishes Gq protein activation without affecting its association with the receptor. J Biol Chem (2000) 0.92
Lorglumide and loxiglumide inhibit gastrin-stimulated DNA synthesis in a rat tumoral acinar pancreatic cell line (AR42J). Cancer Res (1990) 0.92
Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. Proc Natl Acad Sci U S A (1997) 0.91
Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models. Endocrine (2001) 0.91
[Indirect assessment of exocrine pancreatic function by oral administration of a synthetic peptide, N-benzoyl-L-tyrosyl-para-amino-benzoic-acid (PABA test) (author's transl)]. Gastroenterol Clin Biol (1979) 0.91
Secretion of calcium in pancreatic juice. J Physiol (1975) 0.91
sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1. J Biol Chem (1998) 0.91
Gastrin stimulates the formation of a p60Src/p125FAK complex upstream of the phosphatidylinositol 3-kinase signaling pathway. FEBS Lett (1999) 0.91
The peripheral cholecystokinin receptors. Eur J Biochem (1993) 0.90
Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells. Eur J Biochem (1992) 0.90
The amiloride sensitive Na+/H+ antiport in guinea pig pancreatic acini. Characterization and stimulation by caerulein. FEBS Lett (1985) 0.90
Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin. J Biol Chem (1997) 0.89
Interstitial 15q deletion without a classic Prader-Willi phenotype. Am J Med Genet (1991) 0.89
Replication-deficient rSV40 mediate pancreatic gene transfer and long-term inhibition of tumor growth. Cancer Gene Ther (2006) 0.88
Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle. Arch Biochem Biophys (1997) 0.88
Presence of VIP receptors in a human pancreatic adenocarcinoma cell line. Modulation of the cAMP response during cell proliferation. Biochem Biophys Res Commun (1983) 0.88
Gastrin induces tyrosine phosphorylation of Shc proteins and their association with the Grb2/Sos complex. FEBS Lett (1996) 0.88
Transgenic CCK-B/gastrin receptor mediates murine exocrine pancreatic secretion. Gastroenterology (1998) 0.87
Differential regulation of fibroblast growth factor (FGF) receptor-1 mRNA and protein by two molecular forms of basic FGF. Modulation of FGFR-1 mRNA stability. J Biol Chem (1996) 0.87
Does nutritive and non-nutritive sucking reduce other oral behaviors and stimulate rest in calves? J Anim Sci (2002) 0.87
Physiological effect of glucagon in human isolated adipocytes. Horm Metab Res (1995) 0.87
Coupling of pancreatic gastrin/cholecystokinin-B (G/CCKB) receptors to phospholipase C and protein kinase C in AR4-2J tumoral cells. Regul Pept (1994) 0.87
Glucagon-like peptide-1 binding to rat skeletal muscle. Peptides (1995) 0.86
GLP-1 (7-36) amide: effects on glucose transport and metabolism in rat adipose tissue. Horm Metab Res (1997) 0.86
Inhibition of gastrin-induced proliferation of AR4-2J cells by calcium channel antagonists. Int J Cancer (1994) 0.86
Characterization of a LINE retroposon dispersed in the genome of three non-sibling Aedes mosquito species. Gene (1992) 0.86
[Value of caerulein perfusion in functional exploration of exocrine pancreas]. Arch Fr Mal App Dig (1972) 0.86
Functional somatostatin receptors on a rat pancreatic acinar cell line. Am J Physiol (1988) 0.86
Tyrosine phosphorylation of insulin receptor substrate-1 and activation of the PI-3-kinase pathway by glycine-extended gastrin precursors. Biochem Biophys Res Commun (1997) 0.85
Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas. Diabetes (1999) 0.85
Role of cholinergic mechanisms in the response to secretin of isolated canine pancreas. Gastroenterology (1975) 0.85
Differential expression of the CCK-A and CCK-B/gastrin receptor genes in human cancers of the esophagus, stomach and colon. Int J Cancer (1997) 0.85
Cholecystokinin and gastrin peptides stimulate ODC activity in a rat pancreatic cell line. Am J Physiol (1989) 0.84
Dexamethasone effects on somatostatin receptors in pancreatic acinar AR4-2J cells. Biochem Biophys Res Commun (1987) 0.84
[Albumin, IgG and IgA in normal adult human pancreatic juice]. Clin Chim Acta (1971) 0.84
Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179. Eur J Biochem (1993) 0.84
Co-purification of a protein tyrosine phosphatase with activated somatostatin receptors from rat pancreatic acinar membranes. Biochem J (1994) 0.84
Non-parallel enzyme secretion from rat pancreas in vitro studies. J Physiol (1979) 0.84
Transcriptional activation of mouse sst2 somatostatin receptor promoter by transforming growth factor-beta. Involvement of Smad4. J Biol Chem (2001) 0.84
Effects of catecholamines and their inhibitors on the isolated canine pancreas. II. Dopamine. Gastroenterology (1977) 0.84
[Composition of human pancreatic juice. Immunoenzymological studies]. Eur J Biochem (1972) 0.84
Ethanol metabolism by the rat pancreas. Toxicol Appl Pharmacol (1981) 0.84
Relief of ornithine decarboxylase messenger RNA translational repression induced by alternative splicing of its 5' untranslated region. Cancer Res (1996) 0.83
[Studies of the maximum exzymatic capacity of the normal human exocrein pancreas during continous infusion of secretin and pancreozymin]. Biol Gastroenterol (Paris) (1968) 0.83
Calcium and pancreatic secretion-dynamics of subcellur calcium pools in resting and stimulated acinar cells. Br J Pharmacol (1975) 0.83
Gastrin modulates growth of a rat acinar pancreatic cell line: receptor analysis and signal transduction. Digestion (1990) 0.83
Basic fibroblast growth factor induces proliferation of a rat pancreatic cancer cell line. Inhibition by somatostatin. Int J Cancer (1992) 0.83
Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor. J Biol Chem (1999) 0.83
Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells. J Clin Invest (1996) 0.83
Autocrine stimulation of AR4-2J rat pancreatic tumor cell growth by glycine-extended gastrin. Int J Cancer (1996) 0.83
Evidence for specific involvement of 5-HT1A and 5-HT2A/C receptors in the expression of patterns of spontaneous motor activity of the rat. Eur J Pharmacol (1996) 0.83
Inositolphosphoglycans and diacyglycerol are possible mediators in the glycogenic effect of GLP-1(7-36)amide in BC3H-1 myocytes. Cell Biochem Funct (1996) 0.82
Increased HLA-DR homozygosity associated with pre-eclampsia. Hum Reprod (2000) 0.82
Action of secretagogues on amylase release from dog pancreatic acini. Digestion (1981) 0.82
Relationship between bicarbonate, chloride, and volume flow at high secretory rates in the pancreatic juice of the dog. Scand J Gastroenterol (1968) 0.82
Variations in carotenoids, vitamins A and E, and color in cow's plasma and milk following a shift from hay diet to diets containing increasing levels of carotenoids and vitamin E. J Dairy Sci (2007) 0.82
[Comparative study in man of the activity of various currently marketed secretins]. Acta Gastroenterol Belg (1971) 0.82
Binding of somatostatin to pancreatic acinar cells. Am J Physiol (1984) 0.82
Expression of the high molecular weight fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of protein kinases C delta and epsilon and ERK activation. J Biol Chem (2001) 0.82
Studies on human pancreatic acini: action of secretagogues on amylase release and cellular cyclic AMP accumulation. Pancreas (1986) 0.82
Molecular characterization of the solubilized receptor of somatostatin from rat pancreatic acinar membranes. Biochem J (1988) 0.82
A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure. Eur J Biochem (1989) 0.82
Secretin receptors in human pancreatic membranes. Pancreas (1988) 0.82
Amiloride and analogues inhibit Na(+)-H+ exchange and cell proliferation in AR42J pancreatic cell line. Am J Physiol (1990) 0.82
Identification of a region of the N-terminal of the human CCKA receptor essential for the high affinity interaction with agonist CCK. Biochem Biophys Res Commun (1995) 0.82
Neuronal nitric oxide synthase: a substrate for SHP-1 involved in sst2 somatostatin receptor growth inhibitory signaling. FASEB J (2001) 0.82
Morphological and biological modifications induced in a rat pancreatic acinar cancer cell line (AR4-2J) by unscheduled expression of basic fibroblast growth factors. Cancer Res (1993) 0.82
Effect of extreme walking conditions for dairy cows on milk yield, chemical composition, and somatic cell count. J Dairy Sci (1998) 0.81
Distinct activation of Na+-H+ exchange by gastrin and CCK peptide in acini from guinea pig. Am J Physiol (1988) 0.81
In-situ-isolated perfused rat pancreas: a new method for pharmacological studies of the exocrine pancreas. Digestion (1977) 0.81